Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

J Cancer 2020; 11(11):3334-3339. doi:10.7150/jca.42393 This issue Cite

Research Paper

Prevalence and Genotyping of Cryptosporidium parvum in Gastrointestinal Cancer Patients

Nan Zhang1*, Xiuyan Yu2*, Hongbo Zhang3*, Lianying Cui2, Xiaoou Li2, Xiaowei Zhang2, Pengtao Gong3, Jianhua Li3, Ziyi Li1, Xiaocen Wang3, Xin Li3, Ting Li2, Xiaofeng Liu2, Yanhui Yu4✉, Xichen Zhang3✉

1. The First Hospital, Key Laboratory of Zoonosis Research by Ministry of Education, Institute of Zoonosis, Jilin University, Changchun 130021, China.
2. Jilin Cancer Hospital, Changchun 130021, China.
3. Key Laboratory of Zoonosis Research by Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China.
4. Clinical Lab, The Second Hospital, Jilin University, Changchun 130021, China.
*These authors contributed equally to this work.

✉ Corresponding authors: Xichen Zhang, Key Laboratory of Zoonosis Research by Ministry of Education, Institute of Zoonosis, College of Veterinary Medicine, Jilin University, Changchun 130062, China. Email: xczhangedu.cn and Yanhui Yu, Clinical La More

Citation:
Zhang N, Yu X, Zhang H, Cui L, Li X, Zhang X, Gong P, Li J, Li Z, Wang X, Li X, Li T, Liu X, Yu Y, Zhang X. Prevalence and Genotyping of Cryptosporidium parvum in Gastrointestinal Cancer Patients. J Cancer 2020; 11(11):3334-3339. doi:10.7150/jca.42393. https://www.jcancer.org/v11p3334.htm
Other styles

File import instruction

Abstract

Gastrointestinal cancers are the most commonly occurring malignancies which contributing to over 1/5 of cancer incidences worldwide. Increasing evidences have shown that Cryptosporidium spp., an apicomplexan protozoan, is highly associated with gastrointestinal cancers. However, the prevalence of Cryptosporidium spp. infections among gastrointestinal cancer patients in China has not been estimated yet. We here performed a case-control study to evaluate the occurrences of Cryptosporidium spp. in patients with digestive malignancies before chemotherapy and in control population. Nested PCR amplifying 18S rRNA gene was used to detect the presence of Cryptosporidium spp. in each fecal sample. The results herein confirmed the correlation of Cryptosporidium spp. infection with colorectal and liver cancers, while first identified the high frequencies of Cryptosporidium spp. in esophageal cancer and small intestine cancer. The infection rates of Cryptosporidium spp. in colorectal, esophageal, liver and small intestine cancers were 17.24% (20/116, P<0.001), 6.25% (1/16, P=0.029), 14.29% (1/7, P<0.001) and 40% (2/5, P<0.001), respectively. In addition, molecular characterization indicated that all the Cryptosporidium spp. obtained were Cryptosporidium parvum (C. parvum), and the 18S rRNA sequences were identical to the reference sequences isolated from cattle, suggesting potential zoonotic transmission. Furthermore, subtyping analyses revealed that IIaA15G2R1 and IIaA15G2R2 were the predominant subtypes in colorectal cancer, while IIaA13G2R2 subtype was first named and identified in colorectal and liver cancers. Taken together, for the first time, the prevalence of Cryptosporidium spp. infections in digestive cancer patients has been estimated among Chinese. Our results indicated that C. parvum were highly associated with gastrointestinal cancers, supporting that cryptosporidiosis could be a potential risk factor for these diseases.

Keywords: C. parvum, Epidemiology, Colorectal cancer, Liver cancer, Esophageal cancer, Small intestine cancer

Citation styles

APA
Zhang, N., Yu, X., Zhang, H., Cui, L., Li, X., Zhang, X., Gong, P., Li, J., Li, Z., Wang, X., Li, X., Li, T., Liu, X., Yu, Y., Zhang, X. (2020). Prevalence and Genotyping of Cryptosporidium parvum in Gastrointestinal Cancer Patients. Journal of Cancer, 11(11), 3334-3339. https://doi.org/10.7150/jca.42393.

ACS
Zhang, N.; Yu, X.; Zhang, H.; Cui, L.; Li, X.; Zhang, X.; Gong, P.; Li, J.; Li, Z.; Wang, X.; Li, X.; Li, T.; Liu, X.; Yu, Y.; Zhang, X. Prevalence and Genotyping of Cryptosporidium parvum in Gastrointestinal Cancer Patients. J. Cancer 2020, 11 (11), 3334-3339. DOI: 10.7150/jca.42393.

NLM
Zhang N, Yu X, Zhang H, Cui L, Li X, Zhang X, Gong P, Li J, Li Z, Wang X, Li X, Li T, Liu X, Yu Y, Zhang X. Prevalence and Genotyping of Cryptosporidium parvum in Gastrointestinal Cancer Patients. J Cancer 2020; 11(11):3334-3339. doi:10.7150/jca.42393. https://www.jcancer.org/v11p3334.htm

CSE
Zhang N, Yu X, Zhang H, Cui L, Li X, Zhang X, Gong P, Li J, Li Z, Wang X, Li X, Li T, Liu X, Yu Y, Zhang X. 2020. Prevalence and Genotyping of Cryptosporidium parvum in Gastrointestinal Cancer Patients. J Cancer. 11(11):3334-3339.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use